11 unknown, 2 recruiting, 1 completed, 1 withdrawn. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Unknown 11, Recruiting 2, Completed 1, Withdrawn 1 |
Follow IVF: new trials by email Literature Review of IVF trials Research Report on IVF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of G-CSF for DOR in Patients Undergoing IVF Neupogen 300 μg subcutaneous injection, Subcutaneous injections of a saline solution - Diminished Ovarian Reserve, IVF | Phase 4 | Recruiting | Center for Human Reproduction | 140 | 2026-02-25 | 2026-10-13 |
| Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes Progestin, GnRH antagonist - IVF, Fertility Issues | Phase 4 | Unknown | Nesta Clinic | 152 | 2024-08-01 | 2024-07-17 |
| Endometrial Preparation in Frozen Embryo Transfer Cycles estradiol valerate and letrozole, letrozole 2,5 mg tablet - IVF | Phase 4 | Unknown | Rahem Fertility Center | 210 | 2024-02-24 | 2024-02-26 |
| Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. Progesterone 200 MG, Ganirelix Acetate - IVF | Phase 4 | Completed | Instituto Bernabeu | 150 | 2023-12-23 | 2026-03-27 |
| Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes Tadalafil 5mg, estradiol valerate 2 mg - IVF, Infertility, Female | Phase 4 | Recruiting | Beni-Suef University | 100 | 2023-10-01 | 2026-03-30 |
| Comparison of Triggers in Double Ovarian Stimulation (DuoStim). Triptorelin acetate (a-GnRH), Ovitrelle® (hCG), Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together - IVF, LOW OVARIAN RESPONSE | Phase 4 | Unknown | Instituto Bernabeu | 165 | 2022-03-03 | 2022-04-11 |
| Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders A single Gonadotropin-Releasing Hormone (GnRH) antagonist corifollitropin alfa (CFA) stimulation, Up to three modified natural cycles with Follitropin beta. - Ovarian Reserve, Poor Responders | Phase 4 | Unknown | University Hospital, Ghent | 208 | 2022-01-25 | 2024-05-09 |
| GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst Cetrorelix Acetate, Ganerelix Acetate - IVF, Ovarian Cysts | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-05-01 | 2021-10-13 |
| GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth Ganirelix Acetate, Cetrolix Acetate - IVF | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-04-01 | 2021-10-08 |
| Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) Letrozole, estradiol valerate - Infertility, Female, Polycystic Ovary Syndrome | Phase 4 | Withdrawn | CRG UZ Brussel | 2020-12-01 | 2021-01-08 | |
| Desogestrel Versus GnRH Antagonist in IVF/ICSI Desogestrel 0.075 MG, Orgalutran - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 165 | 2020-10-01 | 2021-01-28 |
| The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles Medroxyprogesterone Acetate, Ganirelix Acetate - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 396 | 2020-09-01 | 2020-12-04 |
| FSH Followed by HMG vs FSH Plus HMG in IVF FSH, HP-hMG - IVF | Phase 4 | Unknown | Mansoura University | 530 | 2020-06-30 | 2020-06-09 |
| Use of G-CSF Supplemented IVF Medium in Patients Undergoing IVF G-CSF medium, Control - Infertility, Embryo Development | Phase 4 | Unknown | Centre for Endocrinology and Reproductive Medicine, Italy | 180 | 2016-01-01 | 2016-01-08 |
| Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF Clomiphene citrate, Daily FSH and LH plus Cetrorelix, Triptorelin plus daily FSH anh LH - Poor Responders, IVF | Phase 4 | Unknown | Bioroma | 250 | 2014-01-01 | 2014-07-28 |
Infertility (5) · Infertility, Female (2) · Ovarian Cysts (1) · Polycystic Ovary Syndrome (1)
Genital Diseases (8) · Urogenital Diseases (8) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases, Female (3) · Adnexal Diseases (2) · Cysts (2) · Endocrine System Diseases (2) · Gonadal Disorders (2) · Infertility (2) · Neoplasms (2) · Ovarian Diseases (2) · Ovarian Cysts (1)
ganirelix (4) · Estradiol (3) · Letrozole (2) · Progesterone (2) · Triptorelin Pamoate (2) · cetrorelix (2) · Chorionic Gonadotropin (1) · Clomiphene (1) · Desogestrel (1) · Filgrastim (1) · Gonadotropin-Releasing Hormone (1) · Injections, Subcutaneous (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · Medroxyprogesterone Acetate (1) · Progestins (1)
Assaf-Harofeh Medical Center (2) · Casa di Cura Privata Villa Mafalda (2) · Instituto Bernabeu (2) · Beni-Suef University (1) · Bioroma (1) · CRG UZ Brussel (1) · Center for Human Reproduction (1) · Centre for Endocrinology and Reproductive Medicine, Italy (1) · Mansoura University (1) · Nesta Clinic (1) · Rahem Fertility Center (1) · University Hospital, Ghent (1)
Italy (4) · Egypt (3) · Israel (2) · Spain (2) · Belgium (1) · Turkey (Türkiye) (1) · United States (1)
Ahmed Gibreel, MD (1) · Dominic Stoop, MD, PhD (1) · Eman El-gindy, MD,PhD (1) · Ercan Bastu, M.D. (1) · Francesco Morgia, MS (1) · Hamed Yossef, MD (1) · Hasan El Maghraby, MD (1) · Mohamed S Abdelhafez, MD (1)
PMID 25296696, PMID 25311972, PMID 27567429, PMID 28993105, PMID 30609935, PMID 32208810, PMID 38577571